![Friending viral foes: The Zika story and (perhaps) lessons for COVID-19](https://cdn.cancerletter.com/media/2020/04/Zika-web.jpg)
![Friending viral foes: The Zika story and (perhaps) lessons for COVID-19](https://cdn.cancerletter.com/media/2020/04/Zika-web.jpg)
Cover Story
COVID-19 & CancerFreeGuest Editorial
On a recent call with directors of cancer centers, NCI Director Ned Sharpless reminded us that quarantines present opportunities for scientists to think deeply.
COVID-19 Updates
![COVID-19 Updates](https://cdn.cancerletter.com/media/2021/05/04080942/covid-doodle.jpg)
![COVID-19 Updates](https://cdn.cancerletter.com/media/2021/05/04080942/covid-doodle.jpg)
Clinical Roundup
Drugs & Targets
NCI Trials
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
NCI Trials for April 2020
The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.
Trending Stories
- When tobacco companies sponsored the Olympics
- Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for perioperative indications
- Jonathan Gerber named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access